researchers have developed a new artificial intelligence-based software which may identify and measure the severity of common causes of strokes and
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
"we were fully aware of the fact that our twins would be the first babies in the world to receive this treatment in utero," corinna said.
.